Author:
Cowan Mathew,Swetzig Wendy M.,Adorno-Cruz Valery,Pineda Mario J.,Neubauer Nikki L.,Berry Emily,Lurain John R.,Shahabi Shohreh,Taiym Deanna,Nelson Valerie,O'Shea Kaitlyn Lucrezia,Kocherginsky Masha,Matei Daniela
Subject
Obstetrics and Gynecology,Oncology
Reference40 articles.
1. Fifth ovarian cancer consensus conference of the gynecologic cancer InterGroup: first-line interventions;Karam;Ann. Oncol.,2017
2. NCCN guidelines insights: ovarian cancer, version 1.2019;Armstrong;J. Natl. Compr. Cancer Netw.,2019
3. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan;Gordon;J. Clin. Oncol.,2001
4. Multi-institutional phase 2 study of TLK286 (TELCYTATM, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer;Kavanagh;Int. J. Gynecol. Cancer,2005
5. Better therapeutic trials in ovarian cancer;Bookman;J. Natl. Cancer Inst.,2014
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献